Typhus Group Rickettsiosis and the Dengue Diagnostic Paradox: Low Laboratory-Confirmed Dengue Amid the Americas’ Largest Epidemic
Infectious Disease Reports · 14.07.2026 · 18 (4) · 74
DOI: 10.3390/idr18040074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Disease Reports, online erschienen am 14.07.2026. Verfasst von Manuel Sierra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences, Central American Technological University (UNITEC), Tegucigalpa 11101, Honduras. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Rickettsial diseases, particularly typhus group rickettsioses, remain underrecognized across the Americas despite ecological conditions favorable for transmission. Concurrently, Central America is experiencing one of its largest dengue epidemics, with an unexpectedly low proportion of laboratory-confirmed cases.
Objective
We aimed to explore whether typhus group rickettsioses may contribute to dengue-like febrile illness in Central America in the context of low dengue diagnostic confirmation. Materials and Methods: An analytical narrative review was conducted integrating secondary epidemiological data from the Pan American Health Organization (PAHO) Arbovirus Surveillance Portal and the peer-reviewed literature. Data from seven Central American countries (2024) were analyzed to estimate the proportion of laboratory-confirmed dengue cases. A focused literature review examined epidemiological, clinical, and ecological evidence supporting rickettsial transmission.
Results
Of 543,006 reported dengue cases in Central America in 2024, only 62,285 (11%) were laboratory-confirmed. Evidence from Costa Rica and regional serologic studies suggests ongoing rickettsial transmission. Ecological and socioeconomic conditions—including vector abundance, peridomestic reservoirs, and climate variability—mirror those of South Texas, where murine typhus is endemic.
Conclusions
The discrepancy between reported and confirmed dengue cases suggests a potential diagnostic gap. Typhus group rickettsioses represent a plausible, underrecognized contributor to febrile illness in Central America. Strengthening surveillance, diagnostics, and clinical awareness is essential to address this hidden burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medical Sciences, Central American Technological University (UNITEC), Tegucigalpa 11101, Honduras.
- Department of Internal Medicine and Infectious Disease, Honduran Medical Center, Tegucigalpa 11101, Honduras.
- Faculty of Medical Sciences, Autonomous University of Honduras, Tegucigalpa 11101, Honduras.
- Faculty of Medical Sciences, Latin University of Costa Rica Powered by Arizona State University, San Jose 11501, Costa Rica.
- One Health Research Institute, Central American Technological University (UNITEC), Tegucigalpa 11101, Honduras.
- Department of Infectious Disease and Internal Medicine, Sam Houston State University, Conroe, TX 77304, USA.
ORCID-Profile: Manuel Sierra, Elsa Palou, Fernando Baires, Helen Hoffman, Heike Hesse, Miguel Sierra-Hoffman, Amy C Madril
Zitieren
APA
Sierra, M., Palou, E., Baires, F., Hoffman, H., Hesse, H., Sierra-Hoffman, M., & Madril, A. C. (2026). Typhus Group Rickettsiosis and the Dengue Diagnostic Paradox: Low Laboratory-Confirmed Dengue Amid the Americas’ Largest Epidemic. Infectious Disease Reports, 18(4), 74. https://doi.org/10.3390/idr18040074
Vancouver
Sierra M, Palou E, Baires F, Hoffman H, Hesse H, Sierra-Hoffman M, et al. Typhus Group Rickettsiosis and the Dengue Diagnostic Paradox: Low Laboratory-Confirmed Dengue Amid the Americas’ Largest Epidemic. Infectious Disease Reports. 2026;18(4):74. doi:10.3390/idr18040074
BibTeX
@article{Sierra2026,
author = {Sierra, Manuel and Palou, Elsa and Baires, Fernando and Hoffman, Helen and Hesse, Heike and Sierra-Hoffman, Miguel and Madril, Amy C},
title = {Typhus Group Rickettsiosis and the Dengue Diagnostic Paradox: Low Laboratory-Confirmed Dengue Amid the Americas’ Largest Epidemic},
journal = {Infectious Disease Reports},
year = {2026},
volume = {18},
number = {4},
pages = {74},
doi = {10.3390/idr18040074}
}
EUVIMED